{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:07:16Z","timestamp":1791522436151,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873120"],"award-info":[{"award-number":["81873120"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10557-020-06968-0","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T13:02:45Z","timestamp":1585054965000},"page":"291-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy"],"prefix":"10.1007","volume":"34","author":[{"given":"Tingjuan","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3489-6023","authenticated-orcid":false,"given":"Jufang","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6980-1736","authenticated-orcid":false,"given":"Hangyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"6968_CR1","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S, Abel ED. Diabetic cardiomyopathy revisited. CIRCULATION. 2007;115:3213\u201323.","journal-title":"CIRCULATION"},{"key":"6968_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000064682","volume":"98","author":"CM Schannwell","year":"2002","unstructured":"Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. CARDIOLOGY. 2002;98:33\u20139.","journal-title":"CARDIOLOGY"},{"key":"6968_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","volume":"142","author":"K Huynh","year":"2014","unstructured":"Huynh K, Bernardo BC, McMullen JR, Ritchie RH. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. PHARMACOL THERAPEUT. 2014;142:375\u2013415.","journal-title":"PHARMACOL THERAPEUT"},{"key":"6968_CR4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.4161\/auto.23577","volume":"9","author":"MH Zou","year":"2013","unstructured":"Zou MH, Xie Z. Regulation of interplay between autophagy and apoptosis in the diabetic heart: new role of AMPK. AUTOPHAGY. 2013;9:624\u20135.","journal-title":"AUTOPHAGY"},{"key":"6968_CR5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy. Circ Res. 2018;122:624\u201338.","journal-title":"Circ Res"},{"key":"6968_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1210\/er.2016-1122","volume":"38","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Sun X, Icli B, Feinberg MW. Emerging roles for MicroRNAs in diabetic microvascular disease: novel targets for therapy. Endocr Rev. 2017;38:145\u201368.","journal-title":"Endocr Rev"},{"key":"6968_CR7","doi-asserted-by":"crossref","unstructured":"Zhou Q, Lv D, Chen P, Xu T, Fu S, Li J, et al. MicroRNAs in diabetic cardiomyopathy and clinical perspectives. Front Genet 2014;5:185.","DOI":"10.3389\/fgene.2014.00185"},{"key":"6968_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12933-018-0684-1","volume":"17","author":"N Ghosh","year":"2018","unstructured":"Ghosh N, Katare R. Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides. Cardiovasc Diabetol. 2018;17:43.","journal-title":"Cardiovasc Diabetol"},{"key":"6968_CR9","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ncb2366","volume":"13","author":"YJ Choi","year":"2011","unstructured":"Choi YJ, Lin C, Ho JJ, He X, Okada N, Bu P, et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol. 2011;13:1353\u201360.","journal-title":"Nat Cell Biol"},{"key":"6968_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4161\/auto.27418","volume":"10","author":"K Liu","year":"2014","unstructured":"Liu K, Huang J, Xie M, Yu Y, Zhu S, Kang R, et al. MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell. AUTOPHAGY. 2014;10:442\u201352.","journal-title":"AUTOPHAGY"},{"key":"6968_CR11","first-page":"1125","volume":"20","author":"Y Wu","year":"2017","unstructured":"Wu Y, Dai X, Ni Z, Yan X, He F, Lian J. The downregulation of ATG4B mediated by microRNA-34a\/34c-5p suppresses rapamycin-induced autophagy. IRAN J BASIC MED SCI. 2017;20:1125\u201330.","journal-title":"IRAN J BASIC MED SCI"},{"key":"6968_CR12","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1159\/000475277","volume":"41","author":"L Liu","year":"2017","unstructured":"Liu L, Ren W, Chen K. MiR-34a promotes apoptosis and inhibits autophagy by targeting HMGB1 in acute myeloid leukemia cells. Cell Physiol Biochem. 2017;41:1981\u201392.","journal-title":"Cell Physiol Biochem"},{"key":"6968_CR13","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.3892\/etm.2017.4727","volume":"14","author":"Y Shen","year":"2017","unstructured":"Shen Y, Xu H, Pan X, Wu W, Wang H, Yan L, et al. miR-34a and miR-125b are upregulated in peripheral blood mononuclear cells from patients with type 2 diabetes mellitus. EXP THER MED. 2017;14:5589\u201396.","journal-title":"EXP THER MED"},{"key":"6968_CR14","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.3390\/ijms19092592","volume":"19","author":"Y Chen","year":"2018","unstructured":"Chen Y, Luo H, Sun L, Xu M, Yu J, Liu L, et al. Dihydromyricetin attenuates myocardial hypertrophy induced by transverse aortic constriction via oxidative stress inhibition and SIRT3 pathway enhancement. Int J Mol Sci. 2018;19:2592.","journal-title":"Int J Mol Sci"},{"key":"6968_CR15","doi-asserted-by":"crossref","unstructured":"Zhang Q, Liu J, Liu B, Xia J, Chen N, Chen X, et al. Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism. SCI REP-UK 2015;4:4628.","DOI":"10.1038\/srep04628"},{"key":"6968_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.lfs.2015.03.007","volume":"130","author":"X Hou","year":"2015","unstructured":"Hou X, Tong Q, Wang W, Xiong W, Shi C, Fang J. Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways. Life Sci. 2015;130:38\u201346.","journal-title":"Life Sci"},{"key":"6968_CR17","first-page":"1","volume":"2017","author":"B Wu","year":"2017","unstructured":"Wu B, Lin J, Luo J, Han D, Fan M, Guo T, et al. Dihydromyricetin protects against diabetic cardiomyopathy in streptozotocin-induced diabetic mice. Biomed Res Int. 2017;2017:1\u201313.","journal-title":"Biomed Res Int"},{"key":"6968_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11626-007-9079-4","volume":"44","author":"P Sreejit","year":"2008","unstructured":"Sreejit P, Kumar S, Verma RS. An improved protocol for primary culture of cardiomyocyte from neonatal mice. In Vitro Cellular & Developmental Biology - Animal. 2008;44:45\u201350.","journal-title":"In Vitro Cellular & Developmental Biology - Animal"},{"key":"6968_CR19","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1242\/jcs.01131","volume":"117","author":"Y Kabeya","year":"2004","unstructured":"Kabeya Y, Mizushima N, Yamamoto A, Oshitani-Okamoto S, Ohsumi Y, Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci. 2004;117:2805\u201312.","journal-title":"J Cell Sci"},{"key":"6968_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41590-019-0324-2","volume":"20","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Yao Y, Qiu X, Wang G, Hu Z, Chen S, et al. Listeria hijacks host mitophagy through a novel mitophagy receptor to evade killing. Nat Immunol. 2019;20:433\u201346.","journal-title":"Nat Immunol"},{"key":"6968_CR21","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","volume":"124","author":"WH Dillmann","year":"2019","unstructured":"Dillmann WH. Diabetic cardiomyopathy. Circ Res. 2019;124:1160\u20132.","journal-title":"Circ Res"},{"key":"6968_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. DIABETOLOGIA. 2018;61:21\u20138.","journal-title":"DIABETOLOGIA"},{"key":"6968_CR23","first-page":"1956862462","volume":"10","author":"GS Gulsin","year":"2019","unstructured":"Gulsin GS, Athithan L, McCann GP. Diabetic cardiomyopathy: prevalence, determinants and potential treatments. THER ADV ENDOCRINOL. 2019;10:1956862462.","journal-title":"THER ADV ENDOCRINOL"},{"key":"6968_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.diabet.2018.09.005","volume":"44","author":"F Bonnet","year":"2018","unstructured":"Bonnet F, Scheen AJ. Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: the potential contribution to diabetes complications and cardiovascular disease. Diabetes Metab. 2018;44:457\u201364.","journal-title":"Diabetes Metab"},{"key":"6968_CR25","doi-asserted-by":"crossref","unstructured":"Beddhu S, Chertow GM, Greene T, Whelton PK, Ambrosius WT, Cheung AK, et al. Effects of intensive systolic blood pressure lowering on cardiovascular events and mortality in patients With type 2 diabetes mellitus on standard glycemic control and in those without diabetes mellitus: reconciling results from ACCORD BP and SPRINT. J Am Heart Assoc 2018;7:e009326.","DOI":"10.1161\/JAHA.118.009326"},{"key":"6968_CR26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S2213-8587(17)30258-9","volume":"5","author":"KI Birkeland","year":"2017","unstructured":"Birkeland KI, J\u00f8rgensen ME, Carstensen B, Persson F, Gulseth HL, Thuresson M, et al. Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis. The Lancet Diabetes & Endocrinology. 2017;5:709\u201317.","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"6968_CR27","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1161\/CIRCULATIONAHA.118.036418","volume":"138","author":"JFE Mann","year":"2018","unstructured":"Mann JFE, Fonseca V, Mosenzon O, Raz I, Goldman B, Idorn T, et al. Effects of Liraglutide versus placebo on cardiovascular events in patients with type 2 diabetes mellitus and chronic kidney disease. CIRCULATION. 2018;138:2908\u201318.","journal-title":"CIRCULATION"},{"key":"6968_CR28","doi-asserted-by":"crossref","unstructured":"Mancini SJ, Boyd D, Katwan OJ, Strembitska A, Almabrouk TA, Kennedy S, et al. Canagliflozin inhibits interleukin-1\u03b2-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms. Sci Rep-UK 2018;8:5276.","DOI":"10.1038\/s41598-018-23420-4"},{"key":"6968_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","volume":"71","author":"TH Marwick","year":"2018","unstructured":"Marwick TH, Ritchie R, Shaw JE, Kaye D. Implications of underlying mechanisms for the recognition and Management of Diabetic Cardiomyopathy. J Am Coll Cardiol. 2018;71:339\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"6968_CR30","doi-asserted-by":"crossref","unstructured":"Xu Z, Wang S, Ji H, Zhang Z, Chen J, Tan Y, et al. Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db\/db T2DM mice. Sci Rep-UK 2016;6:30252.","DOI":"10.1038\/srep30252"},{"key":"6968_CR31","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhang Z, Yang Y, Suo Y, Liu R, Qiu J, et al. Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits. Cardiovasc Diabetol 2018;17:160.","DOI":"10.1186\/s12933-018-0803-z"},{"issue":"1","key":"6968_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2019.04.110","volume":"514","author":"Xuelian Li","year":"2019","unstructured":"Li X, Ke X, Li Z, Li B. Vaspin prevents myocardial injury in rats model of diabetic cardiomyopathy by enhancing autophagy and inhibiting inflammation. Biochem Bioph res Co 2019;514(1):1\u20138.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"6968_CR33","first-page":"1","volume":"2017","author":"B Wu","year":"2017","unstructured":"Wu B, Lin J, Luo J, Han D, Fan M, Guo T, et al. Dihydromyricetin protects against diabetic cardiomyopathy in Streptozotocin-induced diabetic mice. Biomed Res Int. 2017;2017:1\u201313.","journal-title":"Biomed Res Int"},{"key":"6968_CR34","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3109\/13880209.2014.948635","volume":"53","author":"G Meng","year":"2014","unstructured":"Meng G, Yang S, Chen Y, Yao W, Zhu H, Zhang W. Attenuating effects of dihydromyricetin on angiotensin II-induced rat cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner. Pharm Biol. 2014;53:904\u201312.","journal-title":"Pharm Biol"},{"key":"6968_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12020-015-0599-5","volume":"50","author":"L Shi","year":"2015","unstructured":"Shi L, Zhang T, Zhou Y, Zeng X, Ran L, Zhang Q, et al. Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1\u03b1-Sirt3 signaling pathway. ENDOCRINE. 2015;50:378\u201389.","journal-title":"ENDOCRINE"},{"key":"6968_CR36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbadis.2014.05.020","volume":"1852","author":"S Kobayashi","year":"2015","unstructured":"Kobayashi S, Liang Q. Autophagy and mitophagy in diabetic cardiomyopathy. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2015;1852:252\u201361.","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"6968_CR37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbadis.2014.06.030","volume":"1852","author":"ZV Varga","year":"2015","unstructured":"Varga ZV, Giricz Z, Liaudet L, Hask\u00f3 G, Ferdinandy P, Pacher P. Interplay of oxidative, nitrosative\/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2015;1852:232\u201342.","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"6968_CR38","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.2337\/db10-0351","volume":"60","author":"Z Xie","year":"2011","unstructured":"Xie Z, Lau K, Eby B, Lozano P, He C, Pennington B, et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. DIABETES. 2011;60:1770\u20138.","journal-title":"DIABETES"},{"key":"6968_CR39","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41418-017-0047-6","volume":"25","author":"I Fomison-Nurse","year":"2018","unstructured":"Fomison-Nurse I, Saw EEL, Gandhi S, Munasinghe PE, Van Hout I, Williams MJA, et al. Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells. Cell Death & Differentiation. 2018;25:1336\u201349.","journal-title":"Cell Death & Differentiation"},{"key":"6968_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature11919","volume":"495","author":"RA Boon","year":"2013","unstructured":"Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, et al. MicroRNA-34a regulates cardiac ageing and function. NATURE. 2013;495:107\u201310.","journal-title":"NATURE"},{"key":"6968_CR41","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2010.07.012","volume":"398","author":"T Ito","year":"2010","unstructured":"Ito T, Yagi S, Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. BIOCHEM BIOPH RES CO. 2010;398:735\u201340.","journal-title":"BIOCHEM BIOPH RES CO"},{"key":"6968_CR42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jdiacomp.2014.01.002","volume":"28","author":"L Zhang","year":"2014","unstructured":"Zhang L, He S, Guo S, Xie W, Xin R, Yu H, et al. Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1. J Diabetes Complicat. 2014;28:259\u201364.","journal-title":"J Diabetes Complicat"},{"key":"6968_CR43","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4161\/auto.27418","volume":"10","author":"K Liu","year":"2014","unstructured":"Liu K, Huang J, Xie M, Yu Y, Zhu S, Kang R, et al. MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell. AUTOPHAGY. 2014;10:442.","journal-title":"AUTOPHAGY"},{"key":"6968_CR44","doi-asserted-by":"publisher","first-page":"e3079","DOI":"10.1038\/cddis.2017.462","volume":"8","author":"J Pang","year":"2017","unstructured":"Pang J, Xiong H, Lin P, Lai L, Yang H, Liu Y, et al. Activation of miR-34a impairs autophagic flux and promotes cochlear cell death via repressing ATG9A: implications for age-related hearing loss. Cell Death and Disease. 2017;8:e3079.","journal-title":"Cell Death and Disease"},{"key":"6968_CR45","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s10753-017-0537-1","volume":"40","author":"L Song","year":"2017","unstructured":"Song L, Zhou F, Cheng L, Hu M, He Y, Zhang B, et al. MicroRNA-34a suppresses autophagy in alveolar type II epithelial cells in acute lung injury by inhibiting FoxO3 expression. INFLAMMATION. 2017;40:927\u201336.","journal-title":"INFLAMMATION"},{"key":"6968_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11357-011-9324-3","volume":"35","author":"J Yang","year":"2013","unstructured":"Yang J, Chen D, He Y, Mel\u00e9ndez A, Feng Z, Hong Q, et al. MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. AGE. 2013;35:11\u201322.","journal-title":"AGE"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-06968-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-020-06968-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-06968-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:19:10Z","timestamp":1616545150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-020-06968-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["6968"],"URL":"https:\/\/doi.org\/10.1007\/s10557-020-06968-0","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"assertion":[{"value":"24 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal protocols were approved by the Animal Care and Use Committee of the Shaoxing Hospital, Zhejiang University School of Medicine. All procedures performed in studies involving animals met the ethical standards of the institution or practice conducting the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}